Log In
Print this Print this

pioglitazone/extended-release metformin (Actoplus met XR)

  Manage Alerts
Collapse Summary General Information
Company Takeda Pharmaceutical Co. Ltd.
DescriptionExtended-release version of ACTOplus met, which combines pioglitazone, a peroxisome proliferation activated receptor (PPAR) gamma agonist, with metformin
Molecular Target Peroxisome proliferation activated receptor (PPAR) gamma
Mechanism of ActionPeroxisome proliferation activated receptor (PPAR) gamma agonist
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentMarketed
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today